UNSPSC 85504350: Bypass left brachial artery to upper arm vein with synthetic substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left brachial artery to upper arm vein with synthetic substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03180JD

UNSPSC 85504350 Bypass left brachial artery to upper arm vein with synthetic substitute, open approach is a Commodity code that nominally describes a specific vascular surgical procedure, but the recent state and local contract opportunities tagged under it show little to no alignment with this scope. The solicitations instead cover occupational medical surveillance, independent medical evaluations for public-safety pension determinations, pharmacy benefit management, temporary health professional staffing, surgical care coordination and Centers of Excellence networks, and inpatient and specialty healthcare services for detained youth. None of these activities map to the procurement or delivery of a vascular bypass graft or related surgical implant or technique. The code shows no recent activity in state and local procurement for the narrowly defined vascular procedure its name indicates.

The geographic distribution of the unrelated opportunities spans Arizona (Phoenix), California (Long Beach and Santa Clara County), Washington State (Department of Transportation), Florida (Collier County), and Texas (Harris County), but this geographic spread reflects the misclassification rather than genuine market activity under the code. No pattern of repeat buyers or concentrated jurisdictional activity emerges. State and local buyers appear to have tagged these health services and staffing opportunities with an incorrect UNSPSC code. The code merits a skip unless you have direct evidence that state and local procurement offices in your target markets are using it correctly for vascular surgical supplies or related orthopedic or general-surgery implants and devices.